PTDC/DTPFTO/2433/2014: MitoBOOST: A Next-Generation Therapeutics for Non-Alcoholic Fatty Liver Disease Based on Smart Antioxidant Delivery to Mitochondria

Funding entity: 
FCT
Budget: 
199.752,00 €
Period covered: 
2016-2019